CME Group (NASDAQ:CME) Earns Sell Rating from Rosenblatt Securities
Rosenblatt Securities restated their sell rating on shares of CME Group (NASDAQ:CME – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm currently has a $180.00 price target on the financial services provider’s stock. Other analysts have also issued reports about the company. Barclays dropped their price target on CME […]
More Stories
TMC the metals Co Inc Increases Registered Direct Offering
TMC the metals Co Inc (NASDAQ:TMC) recently made an amendment to its securities purchase agreement, impacting its registered direct offering....
TSS, Inc. (NASDAQ:TSSI) COO Karl Todd Marrott Sells 29,778 Shares
TSS, Inc. (NASDAQ:TSSI – Get Free Report) COO Karl Todd Marrott sold 29,778 shares of the stock in a transaction...
Insider Selling: CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS) CAO Sells 9,916 Shares of Stock
CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS – Get Free Report) CAO Rodney Christo sold 9,916 shares of CCC Intelligent Solutions...
Financial Comparison: Unity Biotechnology (NASDAQ:UBX) versus PainReform (NASDAQ:PRFX)
Unity Biotechnology (NASDAQ:UBX – Get Free Report) and PainReform (NASDAQ:PRFX – Get Free Report) are both small-cap medical companies, but...
Dell Technologies (NYSE:DELL) Updates FY 2025 Earnings Guidance
Dell Technologies (NYSE:DELL – Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The...
Western Asset Premier Bond Fund (NYSE:WEA) Raises Dividend to $0.07 Per Share
Western Asset Premier Bond Fund (NYSE:WEA – Get Free Report) announced a dividend on Monday, November 25th,NASDAQ Dividends reports. Shareholders...